Industries > Pharma > Cancer Diagnostics Market Report 2021-2031
Cancer Diagnostics Market Report 2021-2031
Forecasts by Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, BRCA Tests, CA-19 Tests, CEA Tests, HER2 Tests, KRAS Mutation Tests, ALK Tests, EGFR Mutation Tests, Others), Imaging (Mammography, Ultrasound, PET Scan, MRI Scan, CT Scan, SPECT & Others), Biopsy (Endoscopic Biopsy, Needle Biopsy, Bone Marrow Biopsy, Others), Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), by Cancer Type (Lung Cancer, Melanoma, Breast Cancer, Colorectal Cancer, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), by End-user (Hospital Associated Labs, Diagnostic Imaging Centers, Independent Diagnostic Laboratories, Cancer Research Institutes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Diagnostics Companies AND COVID-19 Recovery Scenarios
Cancer Diagnostics Market– Our new study reveals trends, R&D progress, and predicted revenues over the next decade
Growing Demand for Non-Invasive Cancer Diagnosis
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market. For instance, VolitionRx Limited, released its Nu.Q colorectal cancer triage test in Europe. Similarly, OncoCyte Corporation, developer of the new DetermaIO, a biomarker of triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) neoadjuvant control point inhibitor response, is expected to be launched in the US by 2H2021. All these factors are anticipated to offer lucrative growth opportunities for the cancer diagnostics market players over the forecast period.
North America Currently Dominates the Global Cancer Diagnostics Market
Based on regions, the global cancer diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to Visiongain analysis, North America cancer diagnostics accounted for majority of the market share and is projected to witness significant growth over the forecast period from 2021 to 2031. The growth is attributed to rising cancer burden which is influenced by many factors, such as aging populations and shift in lifestyle patterns. Patients are encouraged to use healthcare facilities by enhancing compensation. Various cancer prevention programs are organized by government agencies (such as the Colorectal Cancer Control Program) to increase the cancer screening among men & women aged 50 years and above.
How are prominent players reinforcing their position across the global business?
Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies. See where the expected gains will be. View Visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of leading companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and outlook.
Discover how to stay ahead
Our 590+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cancer Diagnostics Market. See how to exploit the opportunities.
Cancer Diagnostics Market Segmentation
Test Type
• Tumor Biomarkers Tests
• PSA Tests
• CTC Tests
• AFP Tests
• CA-19 Tests
• HER2 Tests
• BRCA Tests
• ALK Tests
• CEA Tests
• EGFR Mutation Tests
• KRAS Mutation Tests
• Others
• Imaging
• Ultrasound
• Mammography
• MRI Scan
• PET Scan
• CT Scan
• SPECT & Others
• Biopsy
• Needle Biopsy
• Endoscopic Biopsy
• Bone Marrow Biopsy
• Others
• Liquid Biopsy
• Immunohistochemistry
• In Situ Hybridization
Cancer Type
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Blood Cancer
• Prostate Cancer
• Ovarian Cancer
• Stomach Cancer
• Liver Cancer
• Others
End-User
• Hospital Associated Labs
• Independent Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Other End-Users
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
• Japan
• Asia Pacific Excluding Japan
• China
• Australia
• India
• Singapore
• South Korea
• Thailand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
COVID-19 Impact Recovery Scenarios
This report includes Baseline Forecasts along with Different Rebound Scenarios to help analyze the global Cancer Diagnostics market-no matter how COVID-19 affects the economy.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.
Leading countries and the potential for market growth
Overall world revenue for cancer diagnostics market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Cancer Diagnostics Market report helps you
In summary, our 590+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Cancer Diagnostics Market, with forecasts for production process, application, product, and material, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 21 key national markets– See forecasts for the Cancer Diagnostics market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Germany, UK, France, Italy, Russia, Japan, China, India, Australia, Brazil, Mexico, GCC, and South Africa among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 16 of the major companies involved in the Cancer Diagnostics Market. Some of the companies profiled in this report are Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens AG, Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Quest Diagnostics, Genomic Health (Exact Sciences Corporation), BioMark Diagnostics Inc., Hologic, Inc., QIAGEN, and BD among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Cancer Diagnostics Market and leading companies. You will find data, trends, and predictions.
Who should read this report?
• Senior Executives
• Business Development Managers
• Marketing Directors
• Consultants
• Chief Executive Officers
• Governments, agencies & organizations actively working or interested in the Cancer Diagnostics industry will also find significant value in our research.
Customization Available: Global Cancer Diagnostics Market
• Do you have any custom requirements we can help you with?
• Any specific country, geography, country, market segment or specific company information?
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Cancer Diagnostics Market Report 2021-2031: Forecasts by Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, BRCA Tests, CA-19 Tests, CEA Tests, HER2 Tests, KRAS Mutation Tests, ALK Tests, EGFR Mutation Tests, Others), Imaging (Mammography, Ultrasound, PET Scan, MRI Scan, CT Scan, SPECT & Others), Biopsy (Endoscopic Biopsy, Needle Biopsy, Bone Marrow Biopsy, Others), Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), by Cancer Type (Lung Cancer, Melanoma, Breast Cancer, Colorectal Cancer, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), by End-user (Hospital Associated Labs, Diagnostic Imaging Centers, Independent Diagnostic Laboratories, Cancer Research Institutes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Diagnostics Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Cancer Diagnostics Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Inclusion of Cancer Screening Tests in National Screening Programs
3.1.2 Rising Funding for Cancer Research to Augur Growth
3.1.3 Advances in Imaging Techniques
3.1.4 Growing Demand for Non-Invasive Cancer Diagnosis
3.1.5 Rising Prevalence of Cancer to Boost Cancer Diagnostic Market
3.1.6 Rising Ageing Population Across Emerging Economies to Fuel Cancer Diagnostics Market
3.2 Restraints
3.2.1 Insurance Coverage & Reimbursement Issues
3.2.2 High Research and Development Investment to Hamper Market Growth
3.2.3 Lack of Awareness to Restrain Cancer Diagnostics Market Growth
3.3 Opportunities
3.3.1 Personalized Medicine for Cancer to Offer Lucrative Growth Opportunities
3.3.2 Integration of Artificial Intelligence in Cancer Therapy
3.3.3 Advent of Nano Formulations in Cancer Management
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Industry analysis - Porter’s
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 Industry analysis – PEST Analysis
3.6.1 Political Factors Impacting Cancer Diagnostics Market
3.6.2 Economic Factors Impacting Cancer Diagnostics Market
3.6.3 Social Factors Impacting Cancer Diagnostics Market
3.6.4 Technological Factors Impacting Cancer Diagnostics Market
4 Cancer Diagnostics Market by Test Type
4.1 Tumor Biomarkers Tests Segment Market Forecast, 2021-2031
4.1.1 Technological Advancements to fuel Tumor Biomarkers Segment
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Imaging Segment Market Forecast, 2021-2031
4.2.1 Growing Demand for Early & Accurate Diagnosis to Augur Growth
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Biopsy Segment Market Forecast, 2021-2031
4.3.1 Increasing R&D Funding to Fuel Segment Growth
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Liquid Biopsy Segment Market Forecast, 2021-2031
4.4.1 Increasing Preference of Non-Invasive Procedures to Fuel Segment Growth
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Immunohistochemistry Segment Market Forecast, 2021-2031
4.5.1 Launch of advanced IHC solutions
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 In Situ Hybridization Segment Market Forecast, 2021-2031
4.6.1 Rising penetration of companion diagnostics for cancer detection
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Cancer Diagnostics Market by Cancer Type
5.1 Breast Cancer Segment Market Forecast, 2021-2031
5.1.1 Breast cancer being most diagnosed cancer among the worlds
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Lung Cancer Segment Market Forecast, 2021-2031
5.2.1 Trend of smoking in teenagers to propel segment growth
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Colorectal Cancer Segment Market Forecast, 2021-2031
5.3.1 Genetic factors to play an important role in prevalence of colorectal cancer
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Melanoma Segment Market Forecast, 2021-2031
5.4.1 Strong emerging pipeline to increase the survival rate which in turn likely to propel growth
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Blood Cancer Segment Market Forecast, 2021-2031
5.5.1 Early detection due to DNA tests to mark significant growth in segment revenue
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Prostate Cancer Segment Market Forecast, 2021-2031
5.6.1 Implementation of AI for detection to increase diagnosis rates of prostate cancer
5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.7 Ovarian Cancer Segment Market Forecast, 2021-2031
5.7.1 Rising funding for cancer research to propel growth
5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.8 Stomach Cancer Segment Market Forecast, 2021-2031
5.8.1 Unhealthy diet to increase chances of stomach cancer further growing diagnosis for the same
5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.9 Liver Cancer Segment Market Forecast, 2021-2031
5.9.1 Alcoholism being a major factor in increasing number of liver cancer patients
5.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.10 Others Segment Market Forecast, 2021-2031
5.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Cancer Diagnostics Market by End-User
6.1 Hospital Associated Labs Segment Market Forecast, 2021-2031
6.1.1 Expansion of hospital chains to increase the number of associated labs
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Independent Diagnostic Laboratories Segment Market Forecast, 2021-2031
6.2.1 Availability of high-tech screening instruments to propel growth of the segment
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Diagnostic Imaging Centers Segment Market Forecast, 2021-2031
6.3.1 Large number of imaging centers in developing countries to increase market share
6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 Cancer Research Institutes Segment Market Forecast, 2021-2031
6.4.1 Continuous R&D and funded programs is likely to increase segment revenues
6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Other End-Users Segment Market Forecast, 2021-2031
6.5.1 Cause driven screening camps to propel segment growth
6.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Regional and Leading National Cancer Diagnostics Market Forecasts 2021-2031
7.1 Global Cancer Diagnostics Market by Region Forecast 2021-2031
7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 North America Cancer Diagnostics Market, 2021-2031
8.1 North America Dominates the Worldwide Cancer Diagnostics Market
8.2 North America Cancer Diagnostics Market by Country, Forecast 2021-2031
8.3 North America Cancer Diagnostics Market Forecast by Test Type
8.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031
8.4 North America Cancer Diagnostics Market Forecast by Cancer Type
8.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
8.5 North America Cancer Diagnostics Market Forecast by End-User
8.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by End-User, 2021-2031
8.6 U.S. Cancer Diagnostics Market Forecast, 2021-2031
8.6.1 Large population base and top-notch medical infrastructure to support market expansion
8.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Cancer Diagnostics Market Forecast, 2021-2031
8.7 Canada Cancer Diagnostics Market Forecast, 2021-2031
8.7.1 Improving diagnosis rates to favour lucrative market growth
8.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Cancer Diagnostics Market Forecast, 2021-2031
9 Europe Cancer Diagnostics Market, 2021-2031
9.1 Presence of highly developed MedTech infrastructure to propel cancer diagnosis within the region
9.2 Europe Cancer Diagnostics Market by Country, Forecast 2021-2031
9.3 Europe Cancer Diagnostics Market Forecast by Test Type
9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031
9.4 Europe Cancer Diagnostics Market Forecast by Cancer Type
9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
9.5 Europe Cancer Diagnostics Market Forecast by End-User
9.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031
9.6 Germany Cancer Diagnostics Market Forecast, 2021-2031
9.6.1 Rising healthcare spending and positive healthcare reforms towards cancer screening
9.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Cancer Diagnostics Market Forecast, 2021-2031
9.7 UK Cancer Diagnostics Market Forecast, 2021-2031
9.7.1 Rising incidence of all cancers to propel market expansion
9.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Cancer Diagnostics Market Forecast, 2021-2031
9.8 France Cancer Diagnostics Market Forecast, 2021-2031
9.8.1 Large number of smokers to create a potential candidate for lung cancer screening
9.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Cancer Diagnostics Market Forecast, 2021-2031
9.9 Italy Cancer Diagnostics Market Forecast, 2021-2031
9.9.1 Growing prevalence of prostate cancer to expand market revenues
9.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Cancer Diagnostics Market Forecast, 2021-2031
9.10 Spain Cancer Diagnostics Market Forecast, 2021-2031
9.10.1 Presence of advanced screening centres to propel market growth
9.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Cancer Diagnostics Market Forecast, 2021-2031
9.11 Russia Cancer Diagnostics Market Forecast, 2021-2031
9.11.1 Developing healthcare facilities to increase the demand for cancer screening products
9.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Cancer Diagnostics Market Forecast, 2021-2031
9.12 Poland Cancer Diagnostics Market Forecast, 2021-2031
9.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Poland Cancer Diagnostics Market Forecast, 2021-2031
9.13 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031
9.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031
10 APEJ Cancer Diagnostics Market, 2021-2031
10.1 Rising cases in India and China to increase the regional market
10.2 APEJ Cancer Diagnostics Market by Country, Forecast 2021-2031
10.3 APEJ Cancer Diagnostics Market Forecast by Test Type
10.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031
10.4 APEJ Cancer Diagnostics Market Forecast by Cancer Type
10.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
10.5 APEJ Cancer Diagnostics Market Forecast by End-User
10.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031
10.6 China Cancer Diagnostics Market Forecast, 2021-2031
10.6.1 Large population and well-established healthcare infrastructure to increase market revenues
10.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Cancer Diagnostics Market Forecast, 2021-2031
10.7 Australia Cancer Diagnostics Market Forecast, 2021-2031
10.7.1 Positive government initiatives to propel regional market growth
10.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Cancer Diagnostics Market Forecast, 2021-2031
10.8 India Cancer Diagnostics Market Forecast, 2021-2031
10.8.1 Government funding’s and healthcare reforms to propel market revenues
10.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Cancer Diagnostics Market Forecast, 2021-2031
10.9 Singapore Cancer Diagnostics Market Forecast, 2021-2031
10.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Cancer Diagnostics Market Forecast, 2021-2031
10.10 South Korea Cancer Diagnostics Market Forecast, 2021-2031
10.10.1 Positive government policies likely to improve market for cancer diagnostics
10.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Cancer Diagnostics Market Forecast, 2021-2031
10.11 Thailand Cancer Diagnostics Market Forecast, 2021-2031
10.11.1 Medical tourism to support cancer diagnostics market in Thailand
10.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Thailand Cancer Diagnostics Market Forecast, 2021-2031
10.12 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031
10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031
11 Japan Cancer Diagnostics Market, 2021-2031
11.1 Rising geriatric population susceptible to pancreatic caner to increase market growth
11.2 Japan Cancer Diagnostics Market Forecast by Test Type
11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031
11.3 Japan Cancer Diagnostics Market Forecast by Cancer Type
11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
11.4 Japan Cancer Diagnostics Market Forecast by End-User
11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031
11.5 Japan Cancer Diagnostics Market Forecast, 2021-2031
11.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast, 2021-2031
12 Latin America Cancer Diagnostics Market, 2021-2031
12.1 Cost effective healthcare compared to North America to attract more revenues
12.2 Latin America Cancer Diagnostics Market by Country, Forecast 2021-2031
12.3 Latin America Cancer Diagnostics Market Forecast by Test Type
12.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031
12.4 Latin America Cancer Diagnostics Market Forecast by Cancer Type
12.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
12.5 Latin America Cancer Diagnostics Market Forecast by End-User
12.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031
12.6 Brazil Cancer Diagnostics Market Forecast, 2021-2031
12.6.1 High prevalence rate among middle income groups to increase market for cancer diagnostics
12.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Cancer Diagnostics Market Forecast, 2021-2031
12.7 Mexico Cancer Diagnostics Market Forecast, 2021-2031
12.7.1 Medical tourism to increase revenues for cancer diagnostics
12.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Cancer Diagnostics Market Forecast, 2021-2031
12.8 Argentina Cancer Diagnostics Market Forecast, 2021-2031
12.8.1 Rising incidence rates to increase revenues from cancer diagnostics
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Argentina Cancer Diagnostics Market Forecast, 2021-2031
12.9 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031
12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031
13 MEA Cancer Diagnostics Market, 2021-2031
13.1 Improving healthcare infrastructure to propel regional growth
13.2 MEA Cancer Diagnostics Market by Country, Forecast 2021-2031
13.3 MEA Cancer Diagnostics Market Forecast by Test Type
13.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031
13.4 MEA Cancer Diagnostics Market Forecast by Cancer Type
13.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
13.5 MEA Cancer Diagnostics Market Forecast by End-User
13.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031
13.6 GCC Cancer Diagnostics Market Forecast, 2021-2031
13.6.1 Higher healthcare spending compared to regional counterparts to increase market revenues in future
13.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Cancer Diagnostics Market Forecast, 2021-2031
13.7 South Africa Cancer Diagnostics Market Forecast, 2021-2031
13.7.1 Increasing R&D within the country to expand avenues for cancer diagnostics in south Africa
13.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Cancer Diagnostics Market Forecast, 2021-2031
13.8 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031
13.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031
14 Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.4 Product Benchmarking
14.1.5 Recent Developments
14.1.6 SWOT Analysis
14.2 Thermo Fisher Scientific Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.4 Product Benchmarking
14.2.5 Recent Developments
14.2.6 SWOT Analysis
14.3 Siemens AG
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.3.6 SWOT Analysis
14.4 Bio Rad Laboratories Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.4.6 SWOT Analysis
14.5 GE Healthcare
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.5.6 SWOT Analysis
14.6 Illumina, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.6.6 SWOT Analysis
14.7 Koninklijke Philips N.V.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.7.6 SWOT Analysis
14.8 Canon Medical Systems Corporation
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Agilent Technologies, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.9.6 SWOT Analysis
14.10 Quest Diagnostics
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Recent Developments
14.10.6 SWOT Analysis
14.11 Genomic Health (Exact Sciences Corporation)
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.12 BioMark Diagnostics Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Hologic, Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.4 Product Benchmarking
14.14 Abbott
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.4 Product Benchmarking
14.14.5 SWOT Analysis
14.15 BD
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.4 Product Benchmarking
14.15.5 Recent Developments
14.16 QIAGEN
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations
List of Tables
Table 1 Global Cancer Diagnostics Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 29 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 34 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 35 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 50 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 55 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 60 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 61 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 62 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 63 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 64 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 65 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 70 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 75 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 79 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 80 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 Global Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 85 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 86 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 87 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 88 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 89 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 90 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 91 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 92 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 93 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 94 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 95 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 96 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 97 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 98 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 99 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 100 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 101 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 102 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 103 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 104 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 105 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 106 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 111 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 North America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 116 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 117 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 121 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 126 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 131 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 132 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 133 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 134 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 135 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 136 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Europe Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 141 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 142 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 143 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 144 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 145 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 146 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 147 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 148 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 149 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 150 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 151 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 152 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 153 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 154 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 155 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 156 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 157 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 162 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 167 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 172 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 177 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 182 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 183 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 184 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 185 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 186 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 187 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 188 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 189 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 190 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 191 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 192 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 193 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 194 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 195 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 196 APEJ Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 197 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 213 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 218 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 223 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 228 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 233 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 234 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 235 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 236 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 237 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 238 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 239 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 240 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 241 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 242 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 243 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 244 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 245 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 246 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 247 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 248 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 249 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 250 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 251 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 252 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 253 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 254 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 255 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 256 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 257 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 258 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 259 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 260 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 261 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 262 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 263 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 264 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 265 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 266 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 267 Latin America Cancer Diagnostics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 268 LATAM Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 269 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 270 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 271 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 272 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 273 LATAM Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 274 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 275 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 276 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 277 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 278 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 279 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 280 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 281 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 282 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 283 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 284 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 285 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 286 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 287 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 288 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 289 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 290 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 291 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 292 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 293 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 294 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 295 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 296 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 297 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 298 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 299 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 300 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 301 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 302 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 303 MEA Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 304 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 305 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 306 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 307 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 308 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 309 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 310 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 311 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 312 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 313 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 314 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 315 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 316 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 317 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 318 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 319 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 320 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 321 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 322 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 323 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 324 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 325 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 326 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 327 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 328 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 329 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 330 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 331 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 332 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 333 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 334 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 336 F. Hoffmann-La Roche Ltd.: Recent Developments
Table 337 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 338 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 339 Thermo Fisher Scientific Inc.: Recent Developments
Table 340 Siemens AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 341 Siemens AG: Product Benchmarking
Table 342 Siemens AG: Recent Developments
Table 343 Bio Rad Laboratories Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 344 Bio Rad Laboratories Inc.: Product Benchmarking
Table 345 Bio Rad Laboratories Inc.: Recent Developments
Table 346 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 347 GE Healthcare: Product Benchmarking
Table 348 GE Healthcare: Recent Developments
Table 349 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 350 Illumina, Inc.: Product Benchmarking
Table 351 Illumina, Inc.: Recent Developments
Table 352 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 353 Koninklijke Philips N.V.: Product Benchmarking
Table 354 Koninklijke Philips N.V.: Recent Developments
Table 355 Toshiba Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 356 Canon Medical Systems Corporation: Product Benchmarking
Table 357 Canon Medical Systems Corporation: Recent Developments
Table 358 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 359 Agilent Technologies, Inc.: Product Benchmarking
Table 360 Agilent Technologies, Inc.: Recent Developments
Table 361 Quest Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 362 Quest Diagnostics: Product Benchmarking
Table 363 Quest Diagnostics: Recent Developments
Table 364 Genomic Health (Exact Sciences Corporation): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 365 Genomic Health (Exact Sciences Corporation): Product Benchmarking
Table 366 BioMark Diagnostics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 367 BioMark Diagnostics Inc.: Product Benchmarking
Table 368 BioMark Diagnostics Inc.: Recent Developments
Table 369 Hologic, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 370 Hologic, Inc.: Product Benchmarking
Table 371 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 372 Abbott: Product Benchmarking
Table 373 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 374 BD: Product Benchmarking
Table 375 BD: Recent Developments
Table 376 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 377 QIAGEN: Product Benchmarking
List of Figures
Figure 1 Global Cancer Diagnostics Market: Market Segmentation
Figure 2 Global Cancer Diagnostics Market: Market Trends
Figure 3 Global Cancer Deaths by Age, 2019 (%)
Figure 4 Share of population with Cancer, 2019 (%)
Figure 5 Ageing Population Estimates 2010 - 2050
Figure 6 Global Cancer Diagnostics Market: SWOT Analysis
Figure 7 Porter’s Analysis
Figure 8 PEST Analysis
Figure 9 Global Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR %)
Figure 10 Global Cancer Diagnostics Market Share Forecast by Test Type, 2021, 2026, 2031 (%)
Figure 11 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 12 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 13 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 14 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 15 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 16 Global Cancer Diagnostics Market for Imaging Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 17 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 18 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 19 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 20 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 21 Global Cancer Diagnostics Market for Biopsy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 22 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 23 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 24 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 25 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 26 Global Cancer Diagnostics Market for Liquid Biopsy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 27 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 28 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 29 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 30 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 31 Global Cancer Diagnostics Market for Immunohistochemistry Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 32 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 33 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 34 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 35 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 36 Global Cancer Diagnostics Market for In Situ Hybridization Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 37 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 38 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 39 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 40 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 41 Global Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR %)
Figure 42 Global Cancer Diagnostics Market Share Forecast by Cancer Type, 2021, 2026, 2031 (%)
Figure 43 Global Cancer Diagnostics Market for Breast Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 44 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 45 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 46 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 47 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 48 Global Lung Cancer Statistics, 2020 (Both Sexes)
Figure 49 Global Cancer Diagnostics Market for Lung Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 50 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 51 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 52 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 53 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 54 Global Cancer Diagnostics Market for Colorectal Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 55 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 56 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 57 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 58 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 59 Global Cancer Diagnostics Market for Melanoma Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 60 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 61 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 62 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 63 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 64 Global Cancer Diagnostics Market for Blood Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 65 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 66 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 67 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 68 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 69 Global Prostate Cancer Statistics, 2020 (Both Sexes)
Figure 70 Global Cancer Diagnostics Market for Prostate Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 71 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 Global Cancer Diagnostics Market for Ovarian Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 76 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 Global Cancer Diagnostics Market for Stomach Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 81 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Global Cancer Diagnostics Market for Liver Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 86 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Global Cancer Diagnostics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 91 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 92 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 93 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 94 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 95 Global Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR %)
Figure 96 Global Cancer Diagnostics Market Share Forecast by End-User, 2021, 2026, 2031 (%)
Figure 97 Global Cancer Diagnostics Market for Hospital Associated Labs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 98 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 99 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 100 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 101 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 102 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 103 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 105 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 108 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 109 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 110 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 111 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 112 Global Cancer Diagnostics Market for Cancer Research Institutes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 113 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 114 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 115 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 116 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 117 Global Cancer Diagnostics Market for Other End-Users Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 118 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 119 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 120 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 121 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 122 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ million)
Figure 123 Global Cancer Diagnostics Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 124 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 125 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 126 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 127 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 128 North America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 129 North America Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 130 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 131 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 132 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 133 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 134 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 135 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 136 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 137 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 138 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 139 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 140 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 141 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 142 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 143 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 144 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 145 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 146 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 147 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 148 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 149 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 150 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 151 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 152 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 153 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 154 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 155 Europe Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 156 Europe Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 157 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 158 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 159 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 160 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 161 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 162 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 163 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 164 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 165 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 166 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 167 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 168 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 169 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 170 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 171 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 172 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 173 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 174 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 175 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 176 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 177 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 178 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 179 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 180 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 181 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 182 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 183 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 188 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 193 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 194 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 195 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 196 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 197 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 198 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 199 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 200 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 201 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 202 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 203 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 204 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 205 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 206 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 207 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 208 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 209 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 210 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 211 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 212 APEJ Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 213 APEJ Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 214 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 215 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 216 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 217 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 218 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 219 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 220 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 221 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 222 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 223 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 224 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 225 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 226 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 227 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 228 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 229 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 230 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 231 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 232 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 233 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 234 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 235 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 236 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 237 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 238 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 239 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 240 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 241 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 242 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 243 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 244 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 245 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 246 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 247 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 248 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 249 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 250 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 251 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 252 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 253 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 254 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 255 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 256 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 257 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 258 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 259 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 260 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 261 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 262 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 263 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 264 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 265 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 266 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 267 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 268 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 269 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 270 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 271 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 272 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 273 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 274 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 275 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 276 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 277 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 278 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 279 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 280 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 281 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 282 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 283 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 284 Latin America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 285 Latin America Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 286 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 287 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 288 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 289 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 290 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 291 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 292 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 293 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 294 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 295 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 296 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 297 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 298 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 299 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 300 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 301 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 302 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 303 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 304 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 305 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 306 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 307 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 308 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 309 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 310 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 311 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 312 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 313 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 314 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 315 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 316 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 317 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 318 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 319 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 320 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 321 MEA Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 322 MEA Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 323 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 324 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 325 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 326 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 327 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 328 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 329 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 330 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 331 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 332 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 333 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 334 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 335 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 336 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 337 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 338 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 339 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 340 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 341 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 342 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 343 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 344 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 345 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 346 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 347 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 348 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 349 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 350 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 351 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 352 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 353 F. Hoffmann-La Roche Ltd.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 354 F. Hoffmann-La Roche Ltd.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 355 F. Hoffmann-La Roche Ltd.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 356 F. Hoffmann-La Roche Ltd.: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 357 F. Hoffmann-La Roche Ltd.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 358 SWOT Analysis
Figure 359 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 360 Thermo Fisher Scientific Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 361 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 362 Thermo Fisher Scientific Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 363 Thermo Fisher Scientific Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 364 SWOT Analysis
Figure 365 Siemens AG: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 366 Siemens AG: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 367 Siemens AG: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 368 Siemens AG: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 369 Siemens AG: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 370 SWOT Analysis
Figure 371 Bio Rad Laboratories Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 372 Bio Rad Laboratories Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 373 Bio Rad Laboratories Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 374 Bio Rad Laboratories Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 375 Bio Rad Laboratories Inc.: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 376 SWOT Analysis
Figure 377 GE Healthcare: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 378 GE Healthcare: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 379 GE Healthcare: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 380 GE Healthcare: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 381 SWOT Analysis
Figure 382 Illumina, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 383 Illumina, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 384 Illumina, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 385 Illumina, Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 386 Illumina, Inc.: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 387 SWOT Analysis
Figure 388 Koninklijke Philips N.V.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 389 Koninklijke Philips N.V.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 390 Koninklijke Philips N.V.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 391 Koninklijke Philips N.V.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 392 SWOT Analysis
Figure 393 Canon Medical Systems Corporation: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 394 Canon Medical Systems Corporation: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 395 Canon Medical Systems Corporation: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 396 Canon Medical Systems Corporation: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 397 Agilent Technologies, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 398 Agilent Technologies, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 399 Agilent Technologies, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 400 Agilent Technologies, Inc.: Net Income, 2015-2019 (US$ million, AGR%)
Figure 401 Agilent Technologies, Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 402 SWOT Analysis
Figure 403 Quest Diagnostics: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 404 Quest Diagnostics: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 405 Quest Diagnostics: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 406 Quest Diagnostics: Net Income, 2015-2019 (US$ million, AGR%)
Figure 407 Quest Diagnostics: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 408 SWOT Analysis
Figure 409 Genomic Health (Exact Sciences Corporation): Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 410 Genomic Health (Exact Sciences Corporation): R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 411 Genomic Health (Exact Sciences Corporation): Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 412 Genomic Health (Exact Sciences Corporation): EBDITA, 2015-2019 (US$ million, AGR%)
Figure 413 BioMark Diagnostics Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 414 BioMark Diagnostics Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 415 BioMark Diagnostics Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 416 Hologic, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 417 Hologic, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 418 Hologic, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 419 Abbott: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 420 Abbott: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 421 Abbott: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 422 Abbott: Net Income, 2015-2019 (US$ million, AGR%)
Figure 423 Abbott: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 424 SWOT Analysis
Figure 425 BD: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 426 BD: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 427 BD: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 428 BD: Business Segment Revenue, 2015-2019 (US$ billion, AGR%)
Figure 429 BD: Regional Revenue, 2015-2019 (US$ billion, AGR%)
Figure 430 QIAGEN: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 431 QIAGEN: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 432 QIAGEN: Gross Profit, 2015-2019 (US$ million, AGR%)
1.1 Introduction to Cancer Diagnostics Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Inclusion of Cancer Screening Tests in National Screening Programs
3.1.2 Rising Funding for Cancer Research to Augur Growth
3.1.3 Advances in Imaging Techniques
3.1.4 Growing Demand for Non-Invasive Cancer Diagnosis
3.1.5 Rising Prevalence of Cancer to Boost Cancer Diagnostic Market
3.1.6 Rising Ageing Population Across Emerging Economies to Fuel Cancer Diagnostics Market
3.2 Restraints
3.2.1 Insurance Coverage & Reimbursement Issues
3.2.2 High Research and Development Investment to Hamper Market Growth
3.2.3 Lack of Awareness to Restrain Cancer Diagnostics Market Growth
3.3 Opportunities
3.3.1 Personalized Medicine for Cancer to Offer Lucrative Growth Opportunities
3.3.2 Integration of Artificial Intelligence in Cancer Therapy
3.3.3 Advent of Nano Formulations in Cancer Management
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Industry analysis - Porter’s
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 Industry analysis – PEST Analysis
3.6.1 Political Factors Impacting Cancer Diagnostics Market
3.6.2 Economic Factors Impacting Cancer Diagnostics Market
3.6.3 Social Factors Impacting Cancer Diagnostics Market
3.6.4 Technological Factors Impacting Cancer Diagnostics Market
4 Cancer Diagnostics Market by Test Type
4.1 Tumor Biomarkers Tests Segment Market Forecast, 2021-2031
4.1.1 Technological Advancements to fuel Tumor Biomarkers Segment
4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Imaging Segment Market Forecast, 2021-2031
4.2.1 Growing Demand for Early & Accurate Diagnosis to Augur Growth
4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Biopsy Segment Market Forecast, 2021-2031
4.3.1 Increasing R&D Funding to Fuel Segment Growth
4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.4 Liquid Biopsy Segment Market Forecast, 2021-2031
4.4.1 Increasing Preference of Non-Invasive Procedures to Fuel Segment Growth
4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.5 Immunohistochemistry Segment Market Forecast, 2021-2031
4.5.1 Launch of advanced IHC solutions
4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.6 In Situ Hybridization Segment Market Forecast, 2021-2031
4.6.1 Rising penetration of companion diagnostics for cancer detection
4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Cancer Diagnostics Market by Cancer Type
5.1 Breast Cancer Segment Market Forecast, 2021-2031
5.1.1 Breast cancer being most diagnosed cancer among the worlds
5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Lung Cancer Segment Market Forecast, 2021-2031
5.2.1 Trend of smoking in teenagers to propel segment growth
5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 Colorectal Cancer Segment Market Forecast, 2021-2031
5.3.1 Genetic factors to play an important role in prevalence of colorectal cancer
5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.4 Melanoma Segment Market Forecast, 2021-2031
5.4.1 Strong emerging pipeline to increase the survival rate which in turn likely to propel growth
5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.5 Blood Cancer Segment Market Forecast, 2021-2031
5.5.1 Early detection due to DNA tests to mark significant growth in segment revenue
5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.6 Prostate Cancer Segment Market Forecast, 2021-2031
5.6.1 Implementation of AI for detection to increase diagnosis rates of prostate cancer
5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.7 Ovarian Cancer Segment Market Forecast, 2021-2031
5.7.1 Rising funding for cancer research to propel growth
5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.8 Stomach Cancer Segment Market Forecast, 2021-2031
5.8.1 Unhealthy diet to increase chances of stomach cancer further growing diagnosis for the same
5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.9 Liver Cancer Segment Market Forecast, 2021-2031
5.9.1 Alcoholism being a major factor in increasing number of liver cancer patients
5.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.10 Others Segment Market Forecast, 2021-2031
5.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Cancer Diagnostics Market by End-User
6.1 Hospital Associated Labs Segment Market Forecast, 2021-2031
6.1.1 Expansion of hospital chains to increase the number of associated labs
6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Independent Diagnostic Laboratories Segment Market Forecast, 2021-2031
6.2.1 Availability of high-tech screening instruments to propel growth of the segment
6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Diagnostic Imaging Centers Segment Market Forecast, 2021-2031
6.3.1 Large number of imaging centers in developing countries to increase market share
6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 Cancer Research Institutes Segment Market Forecast, 2021-2031
6.4.1 Continuous R&D and funded programs is likely to increase segment revenues
6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Other End-Users Segment Market Forecast, 2021-2031
6.5.1 Cause driven screening camps to propel segment growth
6.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Regional and Leading National Cancer Diagnostics Market Forecasts 2021-2031
7.1 Global Cancer Diagnostics Market by Region Forecast 2021-2031
7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 North America Cancer Diagnostics Market, 2021-2031
8.1 North America Dominates the Worldwide Cancer Diagnostics Market
8.2 North America Cancer Diagnostics Market by Country, Forecast 2021-2031
8.3 North America Cancer Diagnostics Market Forecast by Test Type
8.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031
8.4 North America Cancer Diagnostics Market Forecast by Cancer Type
8.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
8.5 North America Cancer Diagnostics Market Forecast by End-User
8.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by End-User, 2021-2031
8.6 U.S. Cancer Diagnostics Market Forecast, 2021-2031
8.6.1 Large population base and top-notch medical infrastructure to support market expansion
8.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Cancer Diagnostics Market Forecast, 2021-2031
8.7 Canada Cancer Diagnostics Market Forecast, 2021-2031
8.7.1 Improving diagnosis rates to favour lucrative market growth
8.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Cancer Diagnostics Market Forecast, 2021-2031
9 Europe Cancer Diagnostics Market, 2021-2031
9.1 Presence of highly developed MedTech infrastructure to propel cancer diagnosis within the region
9.2 Europe Cancer Diagnostics Market by Country, Forecast 2021-2031
9.3 Europe Cancer Diagnostics Market Forecast by Test Type
9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031
9.4 Europe Cancer Diagnostics Market Forecast by Cancer Type
9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
9.5 Europe Cancer Diagnostics Market Forecast by End-User
9.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031
9.6 Germany Cancer Diagnostics Market Forecast, 2021-2031
9.6.1 Rising healthcare spending and positive healthcare reforms towards cancer screening
9.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Cancer Diagnostics Market Forecast, 2021-2031
9.7 UK Cancer Diagnostics Market Forecast, 2021-2031
9.7.1 Rising incidence of all cancers to propel market expansion
9.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Cancer Diagnostics Market Forecast, 2021-2031
9.8 France Cancer Diagnostics Market Forecast, 2021-2031
9.8.1 Large number of smokers to create a potential candidate for lung cancer screening
9.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Cancer Diagnostics Market Forecast, 2021-2031
9.9 Italy Cancer Diagnostics Market Forecast, 2021-2031
9.9.1 Growing prevalence of prostate cancer to expand market revenues
9.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Cancer Diagnostics Market Forecast, 2021-2031
9.10 Spain Cancer Diagnostics Market Forecast, 2021-2031
9.10.1 Presence of advanced screening centres to propel market growth
9.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Cancer Diagnostics Market Forecast, 2021-2031
9.11 Russia Cancer Diagnostics Market Forecast, 2021-2031
9.11.1 Developing healthcare facilities to increase the demand for cancer screening products
9.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Cancer Diagnostics Market Forecast, 2021-2031
9.12 Poland Cancer Diagnostics Market Forecast, 2021-2031
9.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Poland Cancer Diagnostics Market Forecast, 2021-2031
9.13 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031
9.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031
10 APEJ Cancer Diagnostics Market, 2021-2031
10.1 Rising cases in India and China to increase the regional market
10.2 APEJ Cancer Diagnostics Market by Country, Forecast 2021-2031
10.3 APEJ Cancer Diagnostics Market Forecast by Test Type
10.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031
10.4 APEJ Cancer Diagnostics Market Forecast by Cancer Type
10.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
10.5 APEJ Cancer Diagnostics Market Forecast by End-User
10.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031
10.6 China Cancer Diagnostics Market Forecast, 2021-2031
10.6.1 Large population and well-established healthcare infrastructure to increase market revenues
10.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Cancer Diagnostics Market Forecast, 2021-2031
10.7 Australia Cancer Diagnostics Market Forecast, 2021-2031
10.7.1 Positive government initiatives to propel regional market growth
10.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Cancer Diagnostics Market Forecast, 2021-2031
10.8 India Cancer Diagnostics Market Forecast, 2021-2031
10.8.1 Government funding’s and healthcare reforms to propel market revenues
10.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Cancer Diagnostics Market Forecast, 2021-2031
10.9 Singapore Cancer Diagnostics Market Forecast, 2021-2031
10.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Cancer Diagnostics Market Forecast, 2021-2031
10.10 South Korea Cancer Diagnostics Market Forecast, 2021-2031
10.10.1 Positive government policies likely to improve market for cancer diagnostics
10.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Cancer Diagnostics Market Forecast, 2021-2031
10.11 Thailand Cancer Diagnostics Market Forecast, 2021-2031
10.11.1 Medical tourism to support cancer diagnostics market in Thailand
10.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Thailand Cancer Diagnostics Market Forecast, 2021-2031
10.12 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031
10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031
11 Japan Cancer Diagnostics Market, 2021-2031
11.1 Rising geriatric population susceptible to pancreatic caner to increase market growth
11.2 Japan Cancer Diagnostics Market Forecast by Test Type
11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031
11.3 Japan Cancer Diagnostics Market Forecast by Cancer Type
11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
11.4 Japan Cancer Diagnostics Market Forecast by End-User
11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031
11.5 Japan Cancer Diagnostics Market Forecast, 2021-2031
11.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast, 2021-2031
12 Latin America Cancer Diagnostics Market, 2021-2031
12.1 Cost effective healthcare compared to North America to attract more revenues
12.2 Latin America Cancer Diagnostics Market by Country, Forecast 2021-2031
12.3 Latin America Cancer Diagnostics Market Forecast by Test Type
12.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031
12.4 Latin America Cancer Diagnostics Market Forecast by Cancer Type
12.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
12.5 Latin America Cancer Diagnostics Market Forecast by End-User
12.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031
12.6 Brazil Cancer Diagnostics Market Forecast, 2021-2031
12.6.1 High prevalence rate among middle income groups to increase market for cancer diagnostics
12.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Cancer Diagnostics Market Forecast, 2021-2031
12.7 Mexico Cancer Diagnostics Market Forecast, 2021-2031
12.7.1 Medical tourism to increase revenues for cancer diagnostics
12.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Cancer Diagnostics Market Forecast, 2021-2031
12.8 Argentina Cancer Diagnostics Market Forecast, 2021-2031
12.8.1 Rising incidence rates to increase revenues from cancer diagnostics
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Argentina Cancer Diagnostics Market Forecast, 2021-2031
12.9 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031
12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031
13 MEA Cancer Diagnostics Market, 2021-2031
13.1 Improving healthcare infrastructure to propel regional growth
13.2 MEA Cancer Diagnostics Market by Country, Forecast 2021-2031
13.3 MEA Cancer Diagnostics Market Forecast by Test Type
13.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031
13.4 MEA Cancer Diagnostics Market Forecast by Cancer Type
13.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
13.5 MEA Cancer Diagnostics Market Forecast by End-User
13.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031
13.6 GCC Cancer Diagnostics Market Forecast, 2021-2031
13.6.1 Higher healthcare spending compared to regional counterparts to increase market revenues in future
13.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Cancer Diagnostics Market Forecast, 2021-2031
13.7 South Africa Cancer Diagnostics Market Forecast, 2021-2031
13.7.1 Increasing R&D within the country to expand avenues for cancer diagnostics in south Africa
13.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Cancer Diagnostics Market Forecast, 2021-2031
13.8 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031
13.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031
14 Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.4 Product Benchmarking
14.1.5 Recent Developments
14.1.6 SWOT Analysis
14.2 Thermo Fisher Scientific Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.4 Product Benchmarking
14.2.5 Recent Developments
14.2.6 SWOT Analysis
14.3 Siemens AG
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.3.6 SWOT Analysis
14.4 Bio Rad Laboratories Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.4.6 SWOT Analysis
14.5 GE Healthcare
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.5.6 SWOT Analysis
14.6 Illumina, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.6.6 SWOT Analysis
14.7 Koninklijke Philips N.V.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.7.6 SWOT Analysis
14.8 Canon Medical Systems Corporation
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Recent Developments
14.9 Agilent Technologies, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.9.6 SWOT Analysis
14.10 Quest Diagnostics
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Recent Developments
14.10.6 SWOT Analysis
14.11 Genomic Health (Exact Sciences Corporation)
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.12 BioMark Diagnostics Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Hologic, Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.4 Product Benchmarking
14.14 Abbott
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.4 Product Benchmarking
14.14.5 SWOT Analysis
14.15 BD
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.4 Product Benchmarking
14.15.5 Recent Developments
14.16 QIAGEN
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations
List of Tables
Table 1 Global Cancer Diagnostics Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 29 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 34 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 35 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 50 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 51 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 52 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 53 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 54 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 55 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 60 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 61 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 62 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 63 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 64 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 65 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 66 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 67 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 68 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 69 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 70 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 71 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 72 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 73 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 74 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 75 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 76 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 77 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 78 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 79 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 80 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 Global Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 85 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 86 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 87 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 88 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 89 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 90 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 91 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 92 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 93 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 94 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 95 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 96 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 97 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 98 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 99 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 100 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 101 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 102 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 103 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 104 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 105 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 106 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
Table 111 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 North America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 116 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 117 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 121 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 126 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 131 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 132 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 133 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 134 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 135 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 136 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Europe Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 141 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 142 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 143 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 144 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 145 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 146 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 147 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 148 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 149 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 150 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 151 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 152 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 153 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 154 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 155 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 156 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 157 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 162 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 167 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 172 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 177 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 182 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 183 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 184 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 185 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 186 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 187 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 188 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 189 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 190 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 191 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 192 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 193 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 194 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 195 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 196 APEJ Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 197 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 198 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 199 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 200 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 201 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 202 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 203 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 208 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 213 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 218 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 223 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 228 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 233 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 234 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 235 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 236 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 237 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 238 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 239 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 240 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 241 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 242 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 243 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 244 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 245 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 246 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 247 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 248 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 249 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 250 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 251 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 252 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 253 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 254 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 255 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 256 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 257 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 258 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 259 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 260 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 261 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 262 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 263 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 264 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 265 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 266 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 267 Latin America Cancer Diagnostics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 268 LATAM Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 269 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 270 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 271 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 272 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 273 LATAM Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 274 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 275 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 276 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 277 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 278 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 279 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 280 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 281 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 282 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 283 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 284 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 285 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 286 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 287 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 288 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 289 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 290 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 291 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 292 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 293 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 294 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 295 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 296 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 297 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 298 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 299 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 300 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 301 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 302 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 303 MEA Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
Table 304 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 305 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 306 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 307 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 308 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 309 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 310 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 311 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 312 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 313 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 314 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 315 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 316 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 317 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 318 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 319 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 320 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 321 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 322 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 323 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 324 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 325 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 326 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 327 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 328 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 329 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 330 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 331 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 332 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 333 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 334 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 336 F. Hoffmann-La Roche Ltd.: Recent Developments
Table 337 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 338 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 339 Thermo Fisher Scientific Inc.: Recent Developments
Table 340 Siemens AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 341 Siemens AG: Product Benchmarking
Table 342 Siemens AG: Recent Developments
Table 343 Bio Rad Laboratories Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 344 Bio Rad Laboratories Inc.: Product Benchmarking
Table 345 Bio Rad Laboratories Inc.: Recent Developments
Table 346 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 347 GE Healthcare: Product Benchmarking
Table 348 GE Healthcare: Recent Developments
Table 349 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 350 Illumina, Inc.: Product Benchmarking
Table 351 Illumina, Inc.: Recent Developments
Table 352 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 353 Koninklijke Philips N.V.: Product Benchmarking
Table 354 Koninklijke Philips N.V.: Recent Developments
Table 355 Toshiba Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 356 Canon Medical Systems Corporation: Product Benchmarking
Table 357 Canon Medical Systems Corporation: Recent Developments
Table 358 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 359 Agilent Technologies, Inc.: Product Benchmarking
Table 360 Agilent Technologies, Inc.: Recent Developments
Table 361 Quest Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 362 Quest Diagnostics: Product Benchmarking
Table 363 Quest Diagnostics: Recent Developments
Table 364 Genomic Health (Exact Sciences Corporation): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 365 Genomic Health (Exact Sciences Corporation): Product Benchmarking
Table 366 BioMark Diagnostics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 367 BioMark Diagnostics Inc.: Product Benchmarking
Table 368 BioMark Diagnostics Inc.: Recent Developments
Table 369 Hologic, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 370 Hologic, Inc.: Product Benchmarking
Table 371 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 372 Abbott: Product Benchmarking
Table 373 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 374 BD: Product Benchmarking
Table 375 BD: Recent Developments
Table 376 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 377 QIAGEN: Product Benchmarking
List of Figures
Figure 1 Global Cancer Diagnostics Market: Market Segmentation
Figure 2 Global Cancer Diagnostics Market: Market Trends
Figure 3 Global Cancer Deaths by Age, 2019 (%)
Figure 4 Share of population with Cancer, 2019 (%)
Figure 5 Ageing Population Estimates 2010 - 2050
Figure 6 Global Cancer Diagnostics Market: SWOT Analysis
Figure 7 Porter’s Analysis
Figure 8 PEST Analysis
Figure 9 Global Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR %)
Figure 10 Global Cancer Diagnostics Market Share Forecast by Test Type, 2021, 2026, 2031 (%)
Figure 11 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 12 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 13 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 14 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 15 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 16 Global Cancer Diagnostics Market for Imaging Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 17 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 18 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 19 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 20 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 21 Global Cancer Diagnostics Market for Biopsy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 22 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 23 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 24 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 25 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 26 Global Cancer Diagnostics Market for Liquid Biopsy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 27 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 28 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 29 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 30 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 31 Global Cancer Diagnostics Market for Immunohistochemistry Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 32 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 33 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 34 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 35 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 36 Global Cancer Diagnostics Market for In Situ Hybridization Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 37 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 38 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 39 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 40 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 41 Global Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR %)
Figure 42 Global Cancer Diagnostics Market Share Forecast by Cancer Type, 2021, 2026, 2031 (%)
Figure 43 Global Cancer Diagnostics Market for Breast Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 44 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 45 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 46 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 47 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 48 Global Lung Cancer Statistics, 2020 (Both Sexes)
Figure 49 Global Cancer Diagnostics Market for Lung Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 50 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 51 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 52 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 53 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 54 Global Cancer Diagnostics Market for Colorectal Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 55 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 56 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 57 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 58 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 59 Global Cancer Diagnostics Market for Melanoma Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 60 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 61 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 62 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 63 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 64 Global Cancer Diagnostics Market for Blood Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 65 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 66 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 67 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 68 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 69 Global Prostate Cancer Statistics, 2020 (Both Sexes)
Figure 70 Global Cancer Diagnostics Market for Prostate Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 71 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 Global Cancer Diagnostics Market for Ovarian Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 76 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 Global Cancer Diagnostics Market for Stomach Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 81 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 Global Cancer Diagnostics Market for Liver Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 86 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Global Cancer Diagnostics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 91 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 92 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 93 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 94 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 95 Global Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR %)
Figure 96 Global Cancer Diagnostics Market Share Forecast by End-User, 2021, 2026, 2031 (%)
Figure 97 Global Cancer Diagnostics Market for Hospital Associated Labs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 98 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 99 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 100 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 101 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 102 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 103 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 105 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 108 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 109 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 110 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 111 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 112 Global Cancer Diagnostics Market for Cancer Research Institutes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 113 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 114 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 115 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 116 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 117 Global Cancer Diagnostics Market for Other End-Users Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 118 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 119 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 120 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 121 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 122 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ million)
Figure 123 Global Cancer Diagnostics Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 124 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 125 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 126 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 127 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 128 North America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 129 North America Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 130 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 131 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 132 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 133 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 134 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 135 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 136 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 137 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 138 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 139 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 140 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 141 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 142 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 143 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 144 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 145 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 146 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 147 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 148 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 149 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 150 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 151 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 152 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 153 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 154 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 155 Europe Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 156 Europe Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 157 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 158 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 159 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 160 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 161 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 162 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 163 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 164 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 165 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 166 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 167 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 168 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 169 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 170 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 171 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 172 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 173 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 174 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 175 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 176 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 177 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 178 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 179 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 180 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 181 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 182 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 183 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 188 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 193 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 194 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 195 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 196 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 197 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 198 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 199 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 200 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 201 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 202 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 203 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 204 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 205 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 206 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 207 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 208 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 209 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 210 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 211 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 212 APEJ Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 213 APEJ Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 214 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 215 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 216 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 217 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 218 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 219 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 220 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 221 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 222 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 223 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 224 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 225 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 226 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 227 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 228 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 229 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 230 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 231 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 232 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 233 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 234 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 235 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 236 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 237 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 238 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 239 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 240 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 241 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 242 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 243 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 244 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 245 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 246 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 247 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 248 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 249 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 250 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 251 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 252 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 253 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 254 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 255 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 256 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 257 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 258 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 259 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 260 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 261 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 262 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 263 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 264 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 265 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 266 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 267 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 268 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 269 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 270 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 271 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 272 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 273 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 274 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 275 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 276 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 277 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 278 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 279 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 280 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 281 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 282 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 283 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 284 Latin America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 285 Latin America Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 286 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 287 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 288 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 289 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 290 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 291 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 292 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 293 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 294 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 295 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 296 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 297 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 298 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 299 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 300 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 301 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 302 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 303 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 304 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 305 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 306 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 307 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 308 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 309 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 310 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 311 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 312 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 313 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 314 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 315 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 316 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 317 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 318 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 319 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 320 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 321 MEA Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
Figure 322 MEA Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 323 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
Figure 324 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 325 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 326 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 327 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 328 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
Figure 329 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 330 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 331 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 332 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 333 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 334 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 335 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 336 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 337 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 338 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 339 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 340 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 341 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 342 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 343 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 344 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 345 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 346 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 347 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 348 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 349 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 350 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 351 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 352 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 353 F. Hoffmann-La Roche Ltd.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 354 F. Hoffmann-La Roche Ltd.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 355 F. Hoffmann-La Roche Ltd.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 356 F. Hoffmann-La Roche Ltd.: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 357 F. Hoffmann-La Roche Ltd.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 358 SWOT Analysis
Figure 359 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 360 Thermo Fisher Scientific Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 361 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 362 Thermo Fisher Scientific Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 363 Thermo Fisher Scientific Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 364 SWOT Analysis
Figure 365 Siemens AG: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 366 Siemens AG: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 367 Siemens AG: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 368 Siemens AG: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 369 Siemens AG: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 370 SWOT Analysis
Figure 371 Bio Rad Laboratories Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 372 Bio Rad Laboratories Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 373 Bio Rad Laboratories Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 374 Bio Rad Laboratories Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 375 Bio Rad Laboratories Inc.: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 376 SWOT Analysis
Figure 377 GE Healthcare: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 378 GE Healthcare: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 379 GE Healthcare: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 380 GE Healthcare: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 381 SWOT Analysis
Figure 382 Illumina, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 383 Illumina, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 384 Illumina, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 385 Illumina, Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 386 Illumina, Inc.: Regional Revenue, 2015-2019 (US$ million, AGR%)
Figure 387 SWOT Analysis
Figure 388 Koninklijke Philips N.V.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 389 Koninklijke Philips N.V.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 390 Koninklijke Philips N.V.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 391 Koninklijke Philips N.V.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 392 SWOT Analysis
Figure 393 Canon Medical Systems Corporation: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 394 Canon Medical Systems Corporation: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 395 Canon Medical Systems Corporation: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 396 Canon Medical Systems Corporation: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 397 Agilent Technologies, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 398 Agilent Technologies, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 399 Agilent Technologies, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 400 Agilent Technologies, Inc.: Net Income, 2015-2019 (US$ million, AGR%)
Figure 401 Agilent Technologies, Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 402 SWOT Analysis
Figure 403 Quest Diagnostics: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 404 Quest Diagnostics: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 405 Quest Diagnostics: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 406 Quest Diagnostics: Net Income, 2015-2019 (US$ million, AGR%)
Figure 407 Quest Diagnostics: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 408 SWOT Analysis
Figure 409 Genomic Health (Exact Sciences Corporation): Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 410 Genomic Health (Exact Sciences Corporation): R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 411 Genomic Health (Exact Sciences Corporation): Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 412 Genomic Health (Exact Sciences Corporation): EBDITA, 2015-2019 (US$ million, AGR%)
Figure 413 BioMark Diagnostics Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 414 BioMark Diagnostics Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 415 BioMark Diagnostics Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
Figure 416 Hologic, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 417 Hologic, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 418 Hologic, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 419 Abbott: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 420 Abbott: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 421 Abbott: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 422 Abbott: Net Income, 2015-2019 (US$ million, AGR%)
Figure 423 Abbott: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
Figure 424 SWOT Analysis
Figure 425 BD: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 426 BD: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 427 BD: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 428 BD: Business Segment Revenue, 2015-2019 (US$ billion, AGR%)
Figure 429 BD: Regional Revenue, 2015-2019 (US$ billion, AGR%)
Figure 430 QIAGEN: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 431 QIAGEN: R&D Expenses, 2015-2019 (US$ million, AGR%)
Figure 432 QIAGEN: Gross Profit, 2015-2019 (US$ million, AGR%)
Companies Profiled in the Report
Abbott
Agilent Technologies, Inc.
BD
Bio Rad Laboratories Inc.
BioMark Diagnostics Inc.
Canon Medical Systems Corporation
F. Hoffmann-La Roche Ltd.
GE Healthcare
Genomic Health (Exact Sciences Corporation)
Hologic, Inc.
Illumina, Inc.
Koninklijke Philips N.V.
QIAGEN
Quest Diagnostics
Siemens AG
Thermo Fisher Scientific Inc.
List of Other Companies
Abbvie
Abz-Pharma GmbH
Accord Healthcare Ltd
Alexion Pharmaceuticals Inc
Amgen
Apotex Europe Bv
AstraZeneca
Berlex Inc
Biocon
Biogen Inc
BioPartners GmbH
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltech, UCB.
Celltrion Healthcare Hungary Kft.
Centocor Ortho Biotech Products LP
Chugai Pharmaceutical Co., Ltd
Coherus Biosciences
Dyax Corp.
Genmab A/S
Genzyme Corp.
Guardant Health
Hexal Ag
Hospira UK Limited
Janssen Biotech Inc
Kyowa Hakko Kirin
Medarex
Medice Arzneimittel Putter GmbH & Co. Kg
MedImmune
Merck
Millennium Pharmaceuticals Inc
MSD
Mylan
Novartis
NovImmmune
Pfizer
Qiagen
Ratiopharm GmbH
Ratiopharm GmbH
Regeneron Pharmaceuticals
Roche
Samsung Bioepis
Sandoz GmbH
Sanofi
Stada Arzneimittel Ag
Sysmex Inostics
Taimed Biologics
Teva GmbH
United Therapeutics Corporation
Wyeth Pharmaceuticals
List of Organizations
American Cancer Society
Angeles Clinic and Research Institute
British Columbia Cancer Agency
Cancer Research Institute
Croatian government
Department of Anatomic Pathology and the Department of Medical Oncology
Drug Controller General of India
European Medicines Agency
European Union
Food and Drug Administration
Government of Romania
Hospital Clínic
Institut Gustave Roussy (Villejuif, France)
National Cancer Institute (NCI)
Netherlands Cancer Institute (Amsterdam)
Organization for Economic Co-operation and Development
Serbian government
Spanish National Cancer Research Center (CNIO)
The Christie Hospital (NHS Foundation Trust)
The Cyclotron Centre Bronowice (CCB)
The National Institutes of Health
The Paula Stradinja University Hospital
United Nations
University of Leeds in the United Kingdom
University of Texas Southwestern Medical Center
World Health Organization
Abbott
Agilent Technologies, Inc.
BD
Bio Rad Laboratories Inc.
BioMark Diagnostics Inc.
Canon Medical Systems Corporation
F. Hoffmann-La Roche Ltd.
GE Healthcare
Genomic Health (Exact Sciences Corporation)
Hologic, Inc.
Illumina, Inc.
Koninklijke Philips N.V.
QIAGEN
Quest Diagnostics
Siemens AG
Thermo Fisher Scientific Inc.
List of Other Companies
Abbvie
Abz-Pharma GmbH
Accord Healthcare Ltd
Alexion Pharmaceuticals Inc
Amgen
Apotex Europe Bv
AstraZeneca
Berlex Inc
Biocon
Biogen Inc
BioPartners GmbH
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltech, UCB.
Celltrion Healthcare Hungary Kft.
Centocor Ortho Biotech Products LP
Chugai Pharmaceutical Co., Ltd
Coherus Biosciences
Dyax Corp.
Genmab A/S
Genzyme Corp.
Guardant Health
Hexal Ag
Hospira UK Limited
Janssen Biotech Inc
Kyowa Hakko Kirin
Medarex
Medice Arzneimittel Putter GmbH & Co. Kg
MedImmune
Merck
Millennium Pharmaceuticals Inc
MSD
Mylan
Novartis
NovImmmune
Pfizer
Qiagen
Ratiopharm GmbH
Ratiopharm GmbH
Regeneron Pharmaceuticals
Roche
Samsung Bioepis
Sandoz GmbH
Sanofi
Stada Arzneimittel Ag
Sysmex Inostics
Taimed Biologics
Teva GmbH
United Therapeutics Corporation
Wyeth Pharmaceuticals
List of Organizations
American Cancer Society
Angeles Clinic and Research Institute
British Columbia Cancer Agency
Cancer Research Institute
Croatian government
Department of Anatomic Pathology and the Department of Medical Oncology
Drug Controller General of India
European Medicines Agency
European Union
Food and Drug Administration
Government of Romania
Hospital Clínic
Institut Gustave Roussy (Villejuif, France)
National Cancer Institute (NCI)
Netherlands Cancer Institute (Amsterdam)
Organization for Economic Co-operation and Development
Serbian government
Spanish National Cancer Research Center (CNIO)
The Christie Hospital (NHS Foundation Trust)
The Cyclotron Centre Bronowice (CCB)
The National Institutes of Health
The Paula Stradinja University Hospital
United Nations
University of Leeds in the United Kingdom
University of Texas Southwestern Medical Center
World Health Organization
Download sample pages
Complete the form below to download your free sample pages for Cancer Diagnostics Market Report 2021-2031Related reports
-
Antibody Drug Conjugates Market Report 2021-2031
Antibody drug conjugate (ADC) technology continues to evolve as a widely successful drug targeting technology for the treatment of cancer....
Full DetailsPublished: 03 November 2020 -
Respiratory Syncytial Virus (RSV) Diagnostics Market Report 2020-2030
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities,...
Full DetailsPublished: 01 January 1970 -
Precision Cancer Diagnostic Test Market Report 2022-2032
The global precision cancer diagnostic test market was valued at US$14,087 million in 2021 and is projected to grow at...Full DetailsPublished: 08 June 2022 -
Precision Cancer Diagnostic Test Market Report 2024-2034
The global Precision Cancer Diagnostic Test Market is projected to grow at a CAGR of 16.1% by 2034...Full DetailsPublished: 17 January 2024 -
Molecular Diagnostics (MDx) Market Report 2022-2032
The global molecular diagnostics market was valued at US$23,498.2 million in 2022 and is projected to grow at a CAGR...Full DetailsPublished: 01 September 2022 -
Biologics Market Report 2022-2032
The global biologics market was valued at US$382.85 billion in 2022 and is projected to grow at a CAGR of...Full DetailsPublished: 04 July 2022 -
Bile Duct Cancer Drugs Market Report to 2031
Where is the Global Bile Duct Cancer Drug market heading? If you are involved in this sector you must read...
Full DetailsPublished: 01 January 1970 -
Antibiotics Market Report 2021-2031
The rising prevalence of tuberculosis, malaria, pneumonia, bacterial skin infections, HIV/AIDS, urinary tract infections (UTI), and other diseases will support...Full DetailsPublished: 15 April 2021 -
Precision Cancer Diagnostic Test Market Report 2021-2031
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without,...Full DetailsPublished: 12 November 2020 -
Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are...Full DetailsPublished: 04 March 2021
Download sample pages
Complete the form below to download your free sample pages for Cancer Diagnostics Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.
11 April 2024
